Ligand id: 9854

Name: pateclizumab

Compound class Antibody
International Nonproprietary Names
INN number INN
9428 pateclizumab
MLTA3698A | PRO283698 | RG7416
Pateclizumab is a humanized anti-lymphotoxin alpha (LTA) monoclonal antibody that is being investigated for anti-inflammatory potential. Peptide sequences for the heavy and light chains of pateclizumab are 100% matches to sequences 106 and 107 that are claimed in Genentech's patent US7923011B2 [1]. Sequences 106 and 107 identify pateclizumab as antibody 2C8.vX as defined in the patent.
Database Links
Specialist databases
IMGT/mAb-DB 383
Other databases
GtoPdb PubChem SID 363894148
Search PubMed clinical trials pateclizumab
Search PubMed titles pateclizumab
Search PubMed titles/abstracts pateclizumab